Report of Foreign Issuer (6-k)
06 Mars 2017 - 12:05PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
Report
of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934
For
the Month of March 2017
333-206723
(Commission File Number)
P.V.
Nano Cell Ltd.
(Exact
name of Registrant as specified in its charter)
8
Hamasger Street
Migdal Ha’Emek, Israel 2310102
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or
Form 40-F.
Form 20-F
þ
Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T
Rule 101(b)(1): ____
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T
Rule 101(b)(7): ____
On February 22, 2017, P.V. Nano Cell
Ltd. (the “Issuer”) made available an updated investor presentation on its website. A copy of the investor presentation
is attached hereto as Exhibit 99.1 and may be viewed in the About Us section of the Company’s website at www.pvnanocell.com.
The Issuer has also prepared two additional investor presentations, (i) a general presentation of the Issuer attached hereto as
Exhibit 99.2 and (ii) a presentation containing certain operational information and forward-looking statements relating to its
LOI to acquire all of the outstanding shares of DigiFlex Ltd., as first reported on February 13, 2017 (the “Digiflex Presentation”),
and representatives of the Issuer presented some or all of this information to potential investors at meetings beginning on February
20, 2017. The Digiflex Presentation is attached hereto as Exhibit 99.3.
Exhibit
Index
Exhibit
No.
|
|
Description
|
99.1
|
|
Investor Presentation (Long-form on website)- February 2017
|
99.2
|
|
Investor Presentation - February 2017
|
99.3
|
|
Digiflex Presentation - February 2017
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
P.V. Nano Cell Ltd.
|
|
|
|
Date: March
3, 2017
|
By:
|
/s/ Fernando
de la Vega
|
|
|
Name: Dr.
Fernando de la Vega
|
|
|
Title: Chief
Executive Officer
|
4
PV Nano Cell (PK) (USOTC:PVNNF)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
PV Nano Cell (PK) (USOTC:PVNNF)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025
Real-Time news about PV Nano Cell Ltd (PK) (OTCMarkets): 0 recent articles
Plus d'articles sur Pv Nano Cell, Ltd.